Global Home Diagnostics for Urinary Tract Infection Market Research Report 2024

Publication ID:

PB503242075

Publication Date:

March 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The urinary tract infection (UTI) is more common among women than in men. The UTI is easy to cure; however, the untreated UTI may lead to a severe health condition. Therefore, there are various diagnostics kits available in the market for UTI. Several diagnostics kits are sold over the counter. The UTI diagnostics works similar to the pregnancy kits; they have a strip, which is held in urine stream for a few seconds or dipping into a sample in a clean cup.
The global Home Diagnostics for Urinary Tract Infection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Home Diagnostics for Urinary Tract Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Home Diagnostics for Urinary Tract Infection.
Report Scope
The Home Diagnostics for Urinary Tract Infection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Home Diagnostics for Urinary Tract Infection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Home Diagnostics for Urinary Tract Infection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
i-Health, Inc (AZO)
F. Hoffmann-La Roche AG (Roche Holding AG)
Acon Laboratories, Inc.
BD
Arkray Inc.
BTNX Inc
Abbott Laboratories
Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
Teco Diagnostics
Atlas Medical
Segment by Type
Dipsticks
Cup
Dipslide
Cassette
Others
Segment by Application
Retail Pharmacies & Drug Store
Online Pharmacies
Supermarket/Hypermarket
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Home Diagnostics for Urinary Tract Infection companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Home Diagnostics for Urinary Tract Infection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dipsticks
1.2.3 Cup
1.2.4 Dipslide
1.2.5 Cassette
1.2.6 Others
1.3 Market by Application
1.3.1 Global Home Diagnostics for Urinary Tract Infection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Retail Pharmacies & Drug Store
1.3.3 Online Pharmacies
1.3.4 Supermarket/Hypermarket
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Home Diagnostics for Urinary Tract Infection Market Perspective (2019-2030)
2.2 Home Diagnostics for Urinary Tract Infection Growth Trends by Region
2.2.1 Global Home Diagnostics for Urinary Tract Infection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Home Diagnostics for Urinary Tract Infection Historic Market Size by Region (2019-2024)
2.2.3 Home Diagnostics for Urinary Tract Infection Forecasted Market Size by Region (2025-2030)
2.3 Home Diagnostics for Urinary Tract Infection Market Dynamics
2.3.1 Home Diagnostics for Urinary Tract Infection Industry Trends
2.3.2 Home Diagnostics for Urinary Tract Infection Market Drivers
2.3.3 Home Diagnostics for Urinary Tract Infection Market Challenges
2.3.4 Home Diagnostics for Urinary Tract Infection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Home Diagnostics for Urinary Tract Infection Players by Revenue
3.1.1 Global Top Home Diagnostics for Urinary Tract Infection Players by Revenue (2019-2024)
3.1.2 Global Home Diagnostics for Urinary Tract Infection Revenue Market Share by Players (2019-2024)
3.2 Global Home Diagnostics for Urinary Tract Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Home Diagnostics for Urinary Tract Infection Revenue
3.4 Global Home Diagnostics for Urinary Tract Infection Market Concentration Ratio
3.4.1 Global Home Diagnostics for Urinary Tract Infection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Home Diagnostics for Urinary Tract Infection Revenue in 2023
3.5 Home Diagnostics for Urinary Tract Infection Key Players Head office and Area Served
3.6 Key Players Home Diagnostics for Urinary Tract Infection Product Solution and Service
3.7 Date of Enter into Home Diagnostics for Urinary Tract Infection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Home Diagnostics for Urinary Tract Infection Breakdown Data by Type
4.1 Global Home Diagnostics for Urinary Tract Infection Historic Market Size by Type (2019-2024)
4.2 Global Home Diagnostics for Urinary Tract Infection Forecasted Market Size by Type (2025-2030)
5 Home Diagnostics for Urinary Tract Infection Breakdown Data by Application
5.1 Global Home Diagnostics for Urinary Tract Infection Historic Market Size by Application (2019-2024)
5.2 Global Home Diagnostics for Urinary Tract Infection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Home Diagnostics for Urinary Tract Infection Market Size (2019-2030)
6.2 North America Home Diagnostics for Urinary Tract Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Home Diagnostics for Urinary Tract Infection Market Size by Country (2019-2024)
6.4 North America Home Diagnostics for Urinary Tract Infection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Home Diagnostics for Urinary Tract Infection Market Size (2019-2030)
7.2 Europe Home Diagnostics for Urinary Tract Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Home Diagnostics for Urinary Tract Infection Market Size by Country (2019-2024)
7.4 Europe Home Diagnostics for Urinary Tract Infection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Home Diagnostics for Urinary Tract Infection Market Size (2019-2030)
8.2 Asia-Pacific Home Diagnostics for Urinary Tract Infection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Home Diagnostics for Urinary Tract Infection Market Size by Region (2019-2024)
8.4 Asia-Pacific Home Diagnostics for Urinary Tract Infection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Home Diagnostics for Urinary Tract Infection Market Size (2019-2030)
9.2 Latin America Home Diagnostics for Urinary Tract Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Home Diagnostics for Urinary Tract Infection Market Size by Country (2019-2024)
9.4 Latin America Home Diagnostics for Urinary Tract Infection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Home Diagnostics for Urinary Tract Infection Market Size (2019-2030)
10.2 Middle East & Africa Home Diagnostics for Urinary Tract Infection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Home Diagnostics for Urinary Tract Infection Market Size by Country (2019-2024)
10.4 Middle East & Africa Home Diagnostics for Urinary Tract Infection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 i-Health, Inc (AZO)
11.1.1 i-Health, Inc (AZO) Company Detail
11.1.2 i-Health, Inc (AZO) Business Overview
11.1.3 i-Health, Inc (AZO) Home Diagnostics for Urinary Tract Infection Introduction
11.1.4 i-Health, Inc (AZO) Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.1.5 i-Health, Inc (AZO) Recent Development
11.2 F. Hoffmann-La Roche AG (Roche Holding AG)
11.2.1 F. Hoffmann-La Roche AG (Roche Holding AG) Company Detail
11.2.2 F. Hoffmann-La Roche AG (Roche Holding AG) Business Overview
11.2.3 F. Hoffmann-La Roche AG (Roche Holding AG) Home Diagnostics for Urinary Tract Infection Introduction
11.2.4 F. Hoffmann-La Roche AG (Roche Holding AG) Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.2.5 F. Hoffmann-La Roche AG (Roche Holding AG) Recent Development
11.3 Acon Laboratories, Inc.
11.3.1 Acon Laboratories, Inc. Company Detail
11.3.2 Acon Laboratories, Inc. Business Overview
11.3.3 Acon Laboratories, Inc. Home Diagnostics for Urinary Tract Infection Introduction
11.3.4 Acon Laboratories, Inc. Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.3.5 Acon Laboratories, Inc. Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Home Diagnostics for Urinary Tract Infection Introduction
11.4.4 BD Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.4.5 BD Recent Development
11.5 Arkray Inc.
11.5.1 Arkray Inc. Company Detail
11.5.2 Arkray Inc. Business Overview
11.5.3 Arkray Inc. Home Diagnostics for Urinary Tract Infection Introduction
11.5.4 Arkray Inc. Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.5.5 Arkray Inc. Recent Development
11.6 BTNX Inc
11.6.1 BTNX Inc Company Detail
11.6.2 BTNX Inc Business Overview
11.6.3 BTNX Inc Home Diagnostics for Urinary Tract Infection Introduction
11.6.4 BTNX Inc Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.6.5 BTNX Inc Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Detail
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Home Diagnostics for Urinary Tract Infection Introduction
11.7.4 Abbott Laboratories Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.7.5 Abbott Laboratories Recent Development
11.8 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
11.8.1 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc) Company Detail
11.8.2 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc) Business Overview
11.8.3 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc) Home Diagnostics for Urinary Tract Infection Introduction
11.8.4 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc) Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.8.5 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc) Recent Development
11.9 Teco Diagnostics
11.9.1 Teco Diagnostics Company Detail
11.9.2 Teco Diagnostics Business Overview
11.9.3 Teco Diagnostics Home Diagnostics for Urinary Tract Infection Introduction
11.9.4 Teco Diagnostics Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.9.5 Teco Diagnostics Recent Development
11.10 Atlas Medical
11.10.1 Atlas Medical Company Detail
11.10.2 Atlas Medical Business Overview
11.10.3 Atlas Medical Home Diagnostics for Urinary Tract Infection Introduction
11.10.4 Atlas Medical Revenue in Home Diagnostics for Urinary Tract Infection Business (2019-2024)
11.10.5 Atlas Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

i-Health, Inc (AZO)
F. Hoffmann-La Roche AG (Roche Holding AG)
Acon Laboratories, Inc.
BD
Arkray Inc.
BTNX Inc
Abbott Laboratories
Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
Teco Diagnostics
Atlas Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂